PSX

Phillips 66 is a classic integrated downstream cyclical, and FY2025 shows the cycle turning back up: net income rebounded +108% to $4.40B and diluted EPS +116% to $10.79, even as revenue fell -7.5% to $132B. The five-year history is the real story — net income swung from $1.32B (2021) to $11.0B (2022) to $2.12B (2024) and back to $4.40B (2025) — so the trailing 15.4x P/E sits on an earnings base that is volatile by nature, not a stable run-rate. At a 0.5x P/S and 15.1% ROE the stock is reasonably, not cheaply, priced for what it is.

The balance sheet and cash returns are the supportive pillars. Liabilities/equity of 1.49x is manageable, retained earnings grew to $33.2B, and operating cash flow rose +18.4% to $4.96B. Management returned $3.1B to shareholders ($1.92B dividends, growing, plus $1.21B buybacks) against that $5B of OCF — a shareholder-friendly posture, though buybacks were cut 65% YoY and the cash balance fell -35.8% to just $1.12B, leaving the company leaning on its $5.7B of committed credit capacity. That thin cash cushion is the one balance-sheet caution.